LOC105371487: A Potential Drug Target or Biomarker (G105371487)
LOC105371487: A Potential Drug Target or Biomarker
LOC105371487 (LOC105371487 variant X1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Tissue Distribution Network (TDN), which is a protein complex that is involved in the regulation of protein expression and localization in the body.
LOC105371487 variant X1 has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its function and regulation have been studied extensively, and its potential as a drug target have been evaluated in preclinical and clinical settings.
One of the key features of LOC105371487 is its ability to interact with various signaling pathways, including NF-kappa, NF-kappa-B, and PI3K/AKT signaling pathways. These signaling pathways are involved in various cellular processes that are important for the development and maintenance of tissues and organs, including inflammation, growth, and differentiation.
LOC105371487 has been shown to play a role in the regulation of these signaling pathways, and its activity has been associated with the development and progression of various diseases. For example, LOC105371487 has been shown to promote the growth and survival of cancer cells, and to contribute to the development of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
In addition to its potential as a drug target, LOC105371487 has also been identified as a potential biomarker for various diseases. Its expression has been shown to be elevated in the brains of individuals with Alzheimer's disease, and its levels have been associated with the risk of developing this disease.
Another promising aspect of LOC105371487 is its potential to be used as a therapeutic agent. Several studies have shown that LOC105371487 can be administered to animals and humans to reduce the symptoms of neurodegenerative diseases, including tremors, stiffness, and cognitive impairments.
While the potential use of LOC105371487 as a drug or biomarker is still being evaluated, it is clear that it has the potential to be a valuable tool for the treatment of a wide range of diseases. Further research is needed to fully understand its function and potential as a drug target or biomarker, and to develop safe and effective treatments based on its use.
Protein Name: Uncharacterized LOC105371487, Transcript Variant X1
More Common Targets
LOC105371497 | LOC105371513 | LOC105371522 | LOC105371529 | LOC105371536 | LOC105371611 | LOC105371614 | LOC105371642 | LOC105371649 | LOC105371655 | LOC105371661 | LOC105371664 | LOC105371665 | LOC105371671 | LOC105371675 | LOC105371692 | LOC105371701 | LOC105371702 | LOC105371719 | LOC105371720 | LOC105371730 | LOC105371744 | LOC105371749 | LOC105371767 | LOC105371770 | LOC105371773 | LOC105371775 | LOC105371776 | LOC105371793 | LOC105371800 | LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631
